Arteriosclerosis stands as one of the leading causes of death worldwide. Among its manifestations, Lower Extremity Artery Disease (LEAD), which has seen a surge in patient numbers recently, is a life-threatening condition. Once it progresses to a severe stage necessitating amputation, the 5-year survival rate is lower than that of certain cancers. It is estimated that tens to hundreds of millions of people globally suffer from gait impairment due to arteriosclerosis.

In the coronary intervention field, stent implantation has been established as a standard revascularization therapy. However, for the lower limbs, particularly in the below-the-knee (BTK) arteries, no definitive device currently exists that can withstand the harsh mechanical environment of flexion, torsion, and deformation associated with walking while maintaining long-term patency. Consequently, the challenge of "restenosis" remains unresolved.

To address this unmet need, we are developing the BioStealth™ Stent, a next-generation scaffold equipped with "stealth" properties designed to minimize recognition as a foreign body within the vessel.

Through this development, we aim to restore compromised blood flow and realize a future where the fundamental happiness of "walking with vitality" is preserved in our aging society.